News search
Research 2 Oct 2023 Scientists at the CNIC have discovered that metabolic cardiovascular risk factors diminish the capacity of the heart to use glucose as an energy source |
About the CNIC 29 Sep 2023 The Spanish National Centre for Cardiovascular Research (CNIC) researcher Dr Ana Paredes has won the International Birnstiel Award 2023 |
Research 31 Aug 2023 A study published in The Lancet Healthy Longevity shows that brain metabolism, detected with advanced imaging techniques, declines more sharply in middle-aged people with a sustained high cardiovascular risk over 5 years |
Research 21 Jun 2023 A new CNIC study shows that low-grade systemic inflammation triggered by subcinical atherosclerosis accelerates epigenetic aging in otherwise healthy young individuals |
Research 29 May 2023 The new study, published in Nature Cardiovascular Research, will help to select the most effective and safe way to modulate angiogenesis in ischemic tissues or in cancer |
Research 21 May 2023 The team led by Dr. Pablo García-Pavía, based at the CNIC and Hospital Puerta de Hierro, has published the first study of a drug able to remove amyloid deposits from the heart |
Research 6 Mar 2023 A study could change management of patients who are not critically ill |
Research 3 Feb 2023 The discovery, published in the journal Immunity, identifies a new therapeutic route for conditions associated with obesity and metabolic syndrome, including cardiovascular disease |
Research 16 Jan 2023 Nature Cardiovascular Research: The 'guardian of the genome' protects against cardiovascular disease A CNIC study extends the understanding of how acquired mutations in blood cells act as a new cardiovascular risk factor |
Research 12 Dec 2022 The results of the SPHERE-HF study are published in the European Journal of Heart Failure. SPHERE-HF is a multicenter academic clinical trial led by investigators at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Hospital Clínic de Barcelona |
- ‹ previous
- 3 of 26
- next ›